PRTA Q4 2023 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$316,000-99.4% YoY

Gross Profit

-$62M-19485.8% margin

Operating Income

-$79M-24846.5% margin

Net Income

-$67M-21353.2% margin

EPS (Diluted)

$-1.26

QoQ Revenue Growth

-99.6%

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$53M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$696M

Total Liabilities

$135M

Stockholders' Equity

$561M

Cash & Equivalents

$619M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$316,000	$50M	-99.4%
Gross Profit	-$62M	$13M	-571.8%
Operating Income	-$79M	-$72,000	-108948.6%
Net Income	-$67M	$6M	-1162.8%

Revenue Segments

Collaboration

$316,000100%